Masimo Corp. (MASI - $130.15) and Danaher Corp. (DHR - $212.58)Announces $9.9 Billion All-Cash Acquisition; Offer Value $180.00/share; Expected Close 2H'2026.DHR announced it has entered into a definitive agreement to acquire MASI, a leading specialty diagnostics provider of pulse oximetry and othe
Figure 1. 4Q25 ResultsSource: Company reports, Wedbush Estimates, Visible Alpha ConsensusExpedia reported strong 4Q results with gross bookings and adj. EBITDA well ahead of estimates. Room night growth in the quarter of +8.8% Y/Y (94mm) was above St. estimates by ~130bps. Gross bookings of $27.0B
Warner Bros. Discovery, Inc. (WBD - $28.11) and Netfilx Inc. (NFLX - $75.86)News Reports Paramount Enlists Top Shareholder in Push to De-Rail Pending Merger.Paramount (PSKY) is in discussions to nominate Matt Halbower, CEO of Pentwater Capital Management, to WBD's board as part of a proxy fight aim
Figure 1. 4Q25 ResultsSource: Company reports, Wedbush estimates, FactSet consensusAirbnb reported strong 4Q results and provided a healthy outlook for 1Q. Nights and Experiences booked growth in 4Q of +15.9% Y/Y was ~560bps above Street estimates. Revenue and adj. EBITDA were ahead of expectations
Figure 1. 4Q25 ResultsSource: Wedbush estimates, Company reportsTripadvisor delivered weak 4Q results. Tripadvisor reported 4Q revenue of $411mm (+0.0% Y/Y), below expectations of +0.5% growth. Performance was in line with management's guide calling flat growth Y/Y in the quarter. Alongside results
Moody's Ratings (Moody's) affirmed Expedia Group, Inc.'s (Expedia) Baa2 senior unsecured notes ratings. At the same time, we changed the outlook to positive from stable. The outlook change to positive reflects Expedia's continued reduction in leverage to 2.1x (Moody's adjusted) as of LTM Q3 2025 a...
Warner Bros. Discovery, Inc. (WBD - $27.98) and Netflix Inc. (NFLX - $84.64)News Reports Paramount Is Not Prepared to Bid Higher. According to Variety, David Ellison's Paramount Skydance (PSKY) has pursued a hostile $30-per-share all-cash takeover bid for WBD (total enterprise value of $108.4 billi
Amicus Therapeutics Inc. (NASDAQ: FOLD - $14.35) and BioMarin Pharmaceutical Inc. (NASDAQ: BMRN - $56.77)Filed Preliminary Proxy; Highlights From Background of Merger Agreement. FOLD filed its preliminary proxy with details regarding the background of BMRN's acquisition of FOLD, beginning with FOLD
Report Overview: Our analysis includes total web visits (desktop and mobile) to U.S. and international web domains, mobile app monthly active users (MAUs), daily active users (DAUs), and total time spent (where applicable). Throughout the report, we display Y/Y changes across each of these key metr
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.